Product Information
ROPINIROLE HCL ER 4 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.5707 per EA under NDC 43547055509. Its NADAC has been published 196 times since Sep 28, 2022.
Strength
4 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547055509
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLEApproval Type
Generic (ANDA)
FDA Application
ANDA204413On Market Since
3/22/2022
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL ER 4 MG TABLET has been published 196 times since Sep 28, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5707 per EA |
|---|---|
| All-time high | $1.0260 (Dec 14, 2022) |
| All-time low | $0.4819 (Nov 20, 2024) |
| 52-week high | $0.8533 |
| 52-week low | $0.5707 |
| Median price | $0.7549 |
| Average price | $0.7441 |
| Largest weekly change | +72.2% (Oct 19, 2022) |
| Weeks tracked | 196 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 88% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL ER 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL ER 4 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.5707 per EA (NDC 43547055509), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL ER 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL ER 4 MG TABLET has held within roughly two percent of its current level. It has been tracked across 196 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL ER 4 MG TABLET?
Since Sep 28, 2022, the NADAC for ROPINIROLE HCL ER 4 MG TABLET has ranged from a low of $0.4819 (Nov 20, 2024) to a high of $1.0260 (Dec 14, 2022), with a median of $0.7549 per EA.
Are there cheaper alternatives to ROPINIROLE HCL ER 4 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ROPINIROLE HCL 4 MG TABLET, is $0.0713 per EA — about 88% below ROPINIROLE HCL ER 4 MG TABLET.
Who manufactures ROPINIROLE HCL ER 4 MG TABLET?
ROPINIROLE HCL ER 4 MG TABLET (NDC 43547055509) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification